Mid-Term Prospective Clinical and Radiographic Outcomes of a Modern Fixed-Bearing Total Ankle Arthroplasty.


Journal

The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons
ISSN: 1542-2224
Titre abrégé: J Foot Ankle Surg
Pays: United States
ID NLM: 9308427

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 03 12 2018
revised: 31 01 2019
accepted: 27 03 2019
entrez: 5 11 2019
pubmed: 5 11 2019
medline: 9 4 2020
Statut: ppublish

Résumé

The early outcomes of the Salto Talaris® Total Ankle Prosthesis have been promising, but information on its mid-term outcomes is still sparse. The purpose of this study was to evaluate the mid-term clinical and radiographic outcomes of this implant among a prospective cohort of patients who underwent total ankle replacement for various etiologies. Forty-six patients (50 ankles) were consecutively enrolled in the study. Our primary aim was to assess implant survivorship as determined by the removal or revision of the implant metal components or conversion to arthrodesis. Our secondary aim was to gauge patient outcomes by using commonly used outcome scores and assess ankle range of motion using goniometric and radiographic methods. We report 100% survivorship of the implant at a mean follow-up of 4.9 years. Compared with preoperative levels, all clinical outcome scores showed significant improvement at the 1-year, 2-year, and 5-year and longer follow-up. The mean clinical ROM improved from 27.7° ± 10.7° preoperatively to 40.0° ± 12.3° at the 2-year follow-up (p < .001). The mean radiographic ROM improved from 23.0° ± 10.2° preoperatively to 27.2° ± 9.1° at the 2-year follow-up (p = .007). Reoperations or secondary procedures were performed on 6 (12%) ankles, with the most common procedure being gutter debridement for impingement symptoms. The study confirms that the excellent survivorship seen with the implant in the early studies extends to mid-term follow-up as well. Patients could expect to see improvement in pain relief and activity well into 5 years after surgery and retain sufficient ankle range of motion for normal gait.

Identifiants

pubmed: 31679668
pii: S1067-2516(19)30104-8
doi: 10.1053/j.jfas.2019.03.014
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1163-1170

Informations de copyright

Copyright © 2019 the American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Richard M Marks (RM)

Professor and Chairman, Department of Orthopaedic Surgery, University of South Alabama, Mobile, AL; Professor, Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, WI. Electronic address: rmmarks@health.southalabama.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH